7-141790989-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018980.3(TAS2R5):āc.628A>Gā(p.Arg210Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000349 in 1,614,122 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018980.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAS2R5 | NM_018980.3 | c.628A>G | p.Arg210Gly | missense_variant | 1/1 | ENST00000247883.5 | NP_061853.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS2R5 | ENST00000247883.5 | c.628A>G | p.Arg210Gly | missense_variant | 1/1 | NM_018980.3 | ENSP00000247883 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152114Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000294 AC: 74AN: 251472Hom.: 0 AF XY: 0.000250 AC XY: 34AN XY: 135912
GnomAD4 exome AF: 0.000365 AC: 533AN: 1461890Hom.: 0 Cov.: 33 AF XY: 0.000360 AC XY: 262AN XY: 727246
GnomAD4 genome AF: 0.000204 AC: 31AN: 152232Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74426
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 26, 2023 | The c.628A>G (p.R210G) alteration is located in exon 1 (coding exon 1) of the TAS2R5 gene. This alteration results from a A to G substitution at nucleotide position 628, causing the arginine (R) at amino acid position 210 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at